ROSIGLITAZON in English translation

• rosiglitazone

Examples of using Rosiglitazon in Danish and their translations into English

Frekvensen af bivirkninger identificeret under kliniske undersøgelser med rosiglitazon.
The frequency of adverse reactions identified from clinical trial data with rosiglitazone.

Rosiglitazon bør derfor ikke anvendes af kvinder, som ammer.
Rosiglitazone should therefore not be used in women who are breast-feeding.

Frekvens af bivirkning under behandlingsregime Rosiglitazon Rosiglitazon med Rosiglitazon med monoterapi metformin metformin og sulfonylurinstof.
Frequency of adverse reaction by treatment regimen Rosiglitazone Rosiglitazone with Rosiglitazone with monotherapy metformin metformin and sulphonylurea.

Både rosiglitazon og glimepirid er påvist i mælken hos forsøgsdyr.
Both rosiglitazone and glimepiride have been detected in the milk of experimental animals.

Frekvens af bivirkning efter behandlingsregime Rosiglitazon monoterapi Rosiglitazon med sulfonylurinstof.
Frequency of adverse reaction by treatment regimen Rosiglitazone monotherapy Rosiglitazone with sulphonylurea.

Begrænsede data er tilgængelige vedrørende overdosering af rosiglitazon hos mennesker.
Limited data are available with regard to overdose of rosiglitazone in humans.

Cmax for rosiglitazon blev formindsket med 32% ved samtidig fødeindtagelse.
For rosiglitazone, Cmax values were decreased by approximately 32% with food.

Rosiglitazon skal seponeres ved enhver klinisk forringelse i den kardiale status.
Rosiglitazone should be discontinued if any deterioration in cardiac status occurs.

Rosiglitazon er i høj grad proteinbundet
Rosiglitazone is highly protein bound

Rosiglitazon passerer den humane placenta og er detekterbar i fostervæv.
Rosiglitazone has been reported to cross the human placenta and to be detectable in foetal tissues.

Rosiglitazon bør administreres samtidigt med den dosis sulfonylurinstof, der allerede tages.
Rosiglitazone 4 mg should be administered concomitantly with the dose of sulphonylurea already being taken.

andre glitazoner f. eks. rosiglitazon.
any glitazone e. g., rosiglitazone.

For dosisrelaterede bivirkninger vil frekvensen afspejle den høje dosis af rosiglitazon.
For dose-related adverse reactions the frequency category reflects the higher dose of rosiglitazone.

Følgende angivelser henviser til de to enkelte aktive delkomponenter rosiglitazon og glimepirid.
The following statements reflect the information available on the individual active substances rosiglitazone and glimepiride.

Rosiglitazon bør seponeres, såfremt der opstår klinisk forringelse i den kardiale status.
Rosiglitazone should be discontinued if any deterioration in cardiac status occurs.

Avandamet- tabletter er en kombination af to forskellige lægemidler kaldet rosiglitazon og metformin.
Avandamet tablets are a combination of two different medicines called rosiglitazone and metformin.

Hver tablet indeholder rosiglitazonmaleat svarende til 4 mg rosiglitazon og 4 mg glimepirid.
Each tablet contains rosiglitazone maleate corresponding to 4 mg rosiglitazone and 4 mg glimepiride.

Avaglim- tabletter er en kombination af to forskellige lægemidler kaldet rosiglitazon og glimepirid.
Avaglim tablets are a combination of two different medicines called rosiglitazone and glimepiride.

Den anbefalede startdosis er 4 mg rosiglitazon og 2000 mg metformin hydroklorid dagligt.
The recommended starting dose is 4 mg rosiglitazone and 2,000 mg metformin hydrochloride a day.

Erfaringer fra kliniske forsøg med rosiglitazon er foreløbig begrænsede til tre år.
Experience from clinical trials with rosiglitazone is currently limited to three years.